E
Adagio Medical Holdings, Inc. ADGM
$0.811 -$0.029-3.45%
Recommendation
Sell
Prev Close
$0.84
Volume
18,882
Avg Vol (90D)
361,646
Market Cap
$12.92M
Dividend & Yield
--
52-Week Range
$0.75 - $11.57
P/E (TTM)
--
EPS (TTM)
-$20.34
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Adagio Medical Holdings Inc Reports Q4 Revenue of $137K and Net Loss of $57.4M
4/2/2025 - GuruFocus
Adagio Medical Appoints Deborah Kaster as Chief Business Officer
3/31/2025 - Business Wire
Adagio Medical Reports Fourth Quarter and Full Year 2024 Results
3/31/2025 - Business Wire
Adagio Medical Holdings CFO Resignation Announced
3/17/2025 - TipRanks Financial Blog
Adagio Medical Provides Clinical and Business Updates
3/17/2025 - Business Wire
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
2/28/2025 - Business Wire
Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference
2/18/2025 - Business Wire
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Adagio Medical Holdings Inc
2/15/2025 - GuruFocus
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Adagio Medical Holdings Inc
2/15/2025 - GuruFocus
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
12/16/2024 - Business Wire
Adagio Medical Reports Third Quarter 2024 Results
11/14/2024 - Business Wire
Perceptive Advisors LLC Acquires Significant Stake in Adagio Medical Holdings Inc
11/14/2024 - GuruFocus
Adagio Medical to Present at the Stifel 2024 Healthcare Conference
11/4/2024 - Business Wire
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
10/24/2024 - Business Wire
Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias
10/7/2024 - Business Wire
Adagio Medical Provides Business Updates
8/19/2024 - Business Wire
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
8/13/2024 - InvestorPlace
Income Statement
Total Revenue (TTM)
$602.00K
EBITDA (TTM)
-$33.57M
EBIT (TTM)
-$34.96M
Net Income (TTM)
-$75.04M
Balance Sheet
Total Assets (Q)
$48.45M
Total Debt (Q)
$16.27M
Total Liabilities (Q)
$28.54M
Book Value Per Share (Q)
$1.31
Cash Flow
Cash from Operations (TTM)
-$29.46M
Cash from Investing (TTM)
-$1.65M
Cash from Financing (TTM)
$15.63M
Net Change in Cash (TTM)
-$15.27M
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Jun 23 and 27 (est)
Price History
Loading...
Beta
0.53
7-Day Total Return
-0.90%
30-Day Total Return
-37.13%
60-Day Total Return
-27.59%
90-Day Total Return
-66.76%
Year to Date Total Return
-30.68%
1-Year Total Return
-92.78%
2-Year Total Return
-92.16%
3-Year Total Return
-91.72%
5-Year Total Return
--
52-week Low
Jan 21, 2025 - $0.75
52-week High
Jul 17, 2024 - $11.57
Valuation
Market Cap
$12.92M - Nano Cap
Enterprise Value
$8.60M
Price/Sales (TTM)
21.37
Price/Book (Q)
0.64
Dividends and Shares
Shares Outstanding
15.32M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
adagiomedical.com
Phone Number
949-348-1188
Address
26051 Merit Circle
Laguna Hills, CA 92653
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It... more
NASDAQ 04/02/2025 4:00PM Eastern Quotes delayed
Weiss Ratings